OGLETHORPE OF ORLANDO INC. — History
CCN 104081 | 3-year financial timeline | COVID resilience: 30/100
🛡️ Public data only — no PHI permitted on this instance.
$13M
Latest Revenue (FY2022)
-7.2%
Revenue CAGR (3yr)
18.7%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $15M | $14M | $13M | -11.7% | -7.2% |
| Operating Expenses | $11M | $11M | $10M | -3.4% | -3.6% |
| Operating Margin | 24.7% | 25.7% | 18.7% | -27.2% | -12.9% |
| Net Income | $4M | $4M | $2M | -35.7% | -19.2% |
| Licensed Beds | 64 | 64 | 64 | +0.0% | +0.0% |
| Total Patient Days | 20,590 | 18,320 | 17,441 | -4.8% | -8.0% |
| Medicare Day % | 79% | 80% | 70% | -12.8% | -6.0% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 30/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -13.9% ($15M → $13M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-7.2%
This Hospital
+7.6%
State Avg
Latest Margin
18.7%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $12M | 15.7% |
| FY2024 (proj) | $11M | 12.8% |
| FY2025 (proj) | $10M | 9.8% |